Skip to main content
Article
Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways
Endocrine
  • Hong Weng Pang, Nova Southeastern University
  • Andrea Linares, Nova Southeastern University
  • Leena Couling, Nova Southeastern University
  • Jessica Santollo, SUNY University at Buffalo; University of Kentucky
  • Leonardo Ancheta, Advanced Targeting Systems
  • Derek Daniels, SUNY University at Buffalo
  • Robert Charles Speth, Nova Southeastern University
ISBN or ISSN
1355-008X
Additional Comments

This study was funded by a President’s Faculty Research Development Grant from Nova Southeastern University and the Cardiovascular Neuroscience Fund, Nova Southeastern University and NIH, HL-113905.

Publication Date / Copyright Date
11-1-2019
Publisher
Springer Nature
DOI Number
10.1007/s12020-019-01930-z
Abstract

PURPOSE: To study the ability of a novel bovine serum albumin-angiotensin II (BSA-Ang II) conjugate to effect responses of the AT

METHODS: Angiotensin II (Ang II) was conjugated with bovine serum albumin and compared with Ang II for competition binding to AT

RESULTS: The BSA-Ang II conjugate was less potent competing for AT

CONCLUSIONS: Addition of a high molecular weight molecule to Ang II reduced its AT

Keywords
  • AT1 receptor; Aldosterone release; Biased agonism; Bovine serum albumin-conjugated angiotensin II; Calcium mobilization; Salt appetite
Rights
© Springer Science + Business Media, LLC, part of Springer Nature 2019
Citation Information
Hong Weng Pang, Andrea Linares, Leena Couling, Jessica Santollo, et al.. "Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways" Endocrine Vol. 66 Iss. 2 (2019) p. 349 - 359
Available at: http://works.bepress.com/robert-speth/47/